Intrexon Corp (XON)

26.12
NYSE : Health Care
Prev Close 25.68
Day Low/High 25.35 / 26.36
52 Wk Low/High 18.52 / 53.39
Avg Volume 1.59M
Exchange NYSE
Shares Outstanding 118.33M
Market Cap 3.04B
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

4 Stocks to Buy in This Vulnerable Market

4 Stocks to Buy in This Vulnerable Market

This market is like a leaky helium balloon; watch out for sudden downdrafts.

Intrexon (XON) Weak On High Volume

Intrexon (XON) Weak On High Volume

Trade-Ideas LLC identified Intrexon (XON) as a weak on high relative volume candidate

Intrexon Introduces Florian™ Switch Technology For Flowering Control

Intrexon Introduces Florian™ Switch Technology For Flowering Control

Genetic "On-Off" Switch Promises Broad, Innovative Applications in Agriculture

13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys

13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys

MIT's Smart 50 list recognizes companies for their combination of innovative technology and effective management, and it includes 13 pharmaceutical and biotech firms this year.

Intrexon (XON) Marked As A Dead Cat Bounce Stock

Intrexon (XON) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Intrexon (XON) as a "dead cat bounce" (down big yesterday but up big today) candidate

Oxitec And Piracicaba City Hall Start Downtown Release Of Friendly™ Aedes

Oxitec And Piracicaba City Hall Start Downtown Release Of Friendly™ Aedes

Expanded project begins Tuesday July 19th; Sao Judas is the first central neighbourhood to receive the mosquito that fights the primary vector of dengue, Zika and chikungunya

Brain Tumor Patient Dies After Ziopharm Gene Therapy Injection

Brain Tumor Patient Dies After Ziopharm Gene Therapy Injection

The circumstances surrounding the Ziopharm patient deaths come amid heightened scrutiny of experimental anti-cancer therapies.

Ziopharm Co-Dependency Spirals Down in Amended Intrexon Deal

Ziopharm Co-Dependency Spirals Down in Amended Intrexon Deal

The amended agreement with Intrexon bolsters the bear argument against Ziopharm that its entire cancer drug pipeline is mediocre and overvalued.

Intrexon (XON) Is Today's Perilous Reversal Stock

Intrexon (XON) Is Today's Perilous Reversal Stock

Trade-Ideas LLC identified Intrexon (XON) as a "perilous reversal" (up big yesterday but down big today) candidate

July 5 Deadline Alert: Law Offices Of Howard G. Smith Reminds Investors Of The Upcoming Deadline In The Class Action Lawsuit Against Intrexon Corporation

July 5 Deadline Alert: Law Offices Of Howard G. Smith Reminds Investors Of The Upcoming Deadline In The Class Action Lawsuit Against Intrexon Corporation

Law Offices of Howard G. Smith reminds investors of the upcoming  July 5, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class") of investors who purchased...

21 Buzzwords That Goldman Sachs Thinks All Investors Should Know Now

21 Buzzwords That Goldman Sachs Thinks All Investors Should Know Now

Ever hear of space congestion, Bots or liquid biopsy? The phrases are part of a group of 21 investment buzzwords identified by Goldman Sachs in its annual buzzword report.

Today's Dead Cat Bounce Stock: Intrexon (XON)

Today's Dead Cat Bounce Stock: Intrexon (XON)

Trade-Ideas LLC identified Intrexon (XON) as a "dead cat bounce" (down big yesterday but up big today) candidate

Intrexon (XON) Weak On High Volume

Intrexon (XON) Weak On High Volume

Trade-Ideas LLC identified Intrexon (XON) as a weak on high relative volume candidate

Intrexon (XON) Strong On High Relative Volume Today

Intrexon (XON) Strong On High Relative Volume Today

Trade-Ideas LLC identified Intrexon (XON) as a strong on high relative volume candidate

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Intrexon Corporation Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 5, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Intrexon Corporation Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 5, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Intrexon Corporation ("Intrexon" or the "Company") (NYSE: XON )...

Starbucks, Nike and Tesla: Doug Kass' Views

Starbucks, Nike and Tesla: Doug Kass' Views

Doug Kass shares his thoughts on Groundhog Day on Wall Street and how brokerages got schmeissed.